Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease

Keyphrases

• Proton Pump Inhibitors 100%
• Maintenance Therapy 100%
• On Demand 100%
• Economic Analysis 100%
• Nonerosive Reflux Disease 100%
• Omeprazole 50%
• Rabeprazole 50%
• Sensitivity Analysis 33%
• Endoscopy 33%
• Pantoprazole 33%
• Esomeprazole 33%
• Lansoprazole 33%
• Proton Pump Inhibitor Therapy 16%
• Complete Resolution 16%
• Heartburn 16%
• Probabilistic Model 16%
• Median Cost 16%
• Expected Cost 16%
• Utility Gains 16%
• UK NHS 16%
• Least Cost 16%
• Model Uncertainty 16%
• Inhibitor Treatment 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Proton Pump Inhibitor 100%
• Non Erosive Reflux Disease 100%
• Omeprazole 42%
• Rabeprazole 42%
• Pantoprazole 28%
• Esomeprazole 28%
• Base 14%
• Heartburn 14%